mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.03 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |